Cargando…
Impact of the number of cycles of platinum-based chemotherapy for early stage ovarian clear cell carcinoma on survival: a retrospective study
BACKGROUND: Ovarian clear cell carcinoma (OCCC) is a unique subtype of ovarian epithelial ovarian cancer. The number of chemotherapy cycles for early-stage patients is still debated. This study aimed to evaluate whether at least 4 cycles of adjuvant platinum-based chemotherapy have better prognostic...
Autor principal: | Gao, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186680/ https://www.ncbi.nlm.nih.gov/pubmed/37189098 http://dx.doi.org/10.1186/s12905-023-02405-0 |
Ejemplares similares
-
Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients
por: Liutkauskiene, Sigita, et al.
Publicado: (2015) -
Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer
por: Chung, Young Shin, et al.
Publicado: (2017) -
Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cycles
por: Kim, Se Ik, et al.
Publicado: (2020) -
Fibrinogen/albumin ratio as a promising predictor of platinum response and survival in ovarian clear cell carcinoma
por: Chen, Wei, et al.
Publicado: (2022) -
Comparative survival analysis of platinum‐based adjuvant chemotherapy for early‐stage squamous cell carcinoma and adenocarcinoma of the lung
por: Hsiao, Shih‐Hsin, et al.
Publicado: (2022)